Pulmonx (LUNG) Gross Profit (2019 - 2025)

Pulmonx (LUNG) has reported Gross Profit for 7 consecutive years, with $16.1 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Gross Profit rose 6.83% year-over-year to $16.1 million in Q3 2025; TTM through Sep 2025 was $67.2 million, a 14.24% increase from a year earlier, with the FY2024 full-year figure at $62.0 million, up 22.16% from the prior year.
• Gross Profit was $16.1 million for Q3 2025 at Pulmonx, down from $17.2 million in the prior quarter.
• Over five years, Gross Profit peaked at $17.6 million in Q4 2024 and troughed at $6.6 million in Q1 2021.
• A 5-year average of $12.5 million and a median of $12.7 million in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit surged 792.19% in 2021 and grew 4.24% in 2022, its largest moves.
• Over 5 years, Gross Profit stood at $10.3 million in 2021, then gained by 9.1% to $11.2 million in 2022, then climbed by 28.76% to $14.4 million in 2023, then increased by 22.15% to $17.6 million in 2024, then slipped by 8.74% to $16.1 million in 2025.
• The last three Gross Profit figures came in at $16.1 million (Q3 2025), $17.2 million (Q2 2025), and $16.3 million (Q1 2025), per Business Quant data.